European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu konsensus - konference, časopisecké články
Grantová podpora
United European Gastroenterology
University of Pavia
PubMed
40088199
PubMed Central
PMC12188380
DOI
10.1002/ueg2.70011
Knihovny.cz E-zdroje
- Klíčová slova
- breath test, coeliac disease, diarrhoea, enteropathy, nutrition, pancreatitis, weight loss,
- MeSH
- celiakie diagnóza terapie MeSH
- dítě MeSH
- exokrinní pankreatická insuficience komplikace diagnóza terapie MeSH
- gastroenterologie * normy MeSH
- konsensus MeSH
- lidé MeSH
- malabsorpční syndromy * diagnóza terapie etiologie epidemiologie MeSH
- nutriční podpora * metody normy MeSH
- plošný screening * metody normy MeSH
- primární zdravotní péče normy MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- společnosti lékařské MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- Geografické názvy
- Evropa MeSH
Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or global malabsorption in both children and adults, such as cystic fibrosis, exocrine pancreatic insufficiency (EPI), coeliac disease (CD) and other enteropathies, lactase deficiency, small intestinal bacterial overgrowth (SIBO), autoimmune atrophic gastritis, Crohn's disease, and gastric or small bowel resections. Early recognition of malabsorption is key for tailoring a proper diagnostic work-up for identifying the cause of malabsorption. Patient's medical and pharmacological history are essential for identifying risk factors. Several examinations like endoscopy with small intestinal biopsies, non-invasive functional tests, and radiologic imaging are useful in diagnosing malabsorption. Due to its high prevalence, CD should always be looked for in case of malabsorption with no other obvious explanations and in high-risk individuals. Nutritional support is key in management of patients with malabsorption; different options are available, including oral supplements, enteral or parenteral nutrition. In patients with short bowel syndrome, teduglutide proved effective in reducing the need for parenteral nutrition, thus improving the quality of life of these patients. Primary care physicians have a central role in early detection of malabsorption and should be involved into multidisciplinary teams for improving the overall management of these patients. In this European consensus, involving 10 scientific societies and several experts, we have dissected all the issues around malabsorption, including the definitions and diagnostic testing (Part 1), high-risk categories and special populations, nutritional assessment and management, and primary care perspective (Part 2).
1st Department of Internal Medicine Fondazione IRCCS San Matteo Pavia Italy
2nd Medical Department Emergency Clinical County Hospital Cluj Napoca Romania
CEMAD Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy
Department of Gastroenterology and Hepatology Medical University of Vienna Vienna Austria
Department of Hepatogastroenterology IKEM Prague Czech Republic
Department of Internal Diseases Rīga Stradiņš University Riga Latvia
Department of Internal Medicine and Medical Therapeutics University of Pavia Pavia Italy
Department of Medical and Surgical Sciences University of Bologna Bologna Italy
Department of Translational Medicine and Surgery Università Cattolica del Sacro Cuore Rome Italy
Faculty of Medicine University of Maribor Maribor Slovenia
Gastroenterology Department Hospital Garcia de Orta Almada Portugal
Israelitic Hospital Academic Hospital University of Hamburg Hamburg Germany
Laboratory of Health and Society School of Medicine University of Crete Heraklion Greece
Zobrazit více v PubMed
Corazza G. R., Frisoni M., Treggiari E. A., et al., “Subclinical Celiac Sprue. Increasing Occurrence and Clues to its Diagnosis,” Journal of Clinical Gastroenterology 16, no. 1 (1993): 16–21, 10.1097/00004836-199301000-00006. PubMed DOI
Bardella M. T., Fredella C., Saladino V., et al., “Gluten Intolerance: Gender‐ and Age‐Related Differences in Symptoms,” Scandinavian Journal of Gastroenterology 40, no. 1 (2005): 15–19, 10.1080/00365520410008169. PubMed DOI
Abu D. H., Lebwohl B., Smukalla S., Lewis S. K., and Green P. H., “Utilizing HDL Levels to Improve Detection of Celiac Disease in Patients With Iron Deficiency Anemia,” American Journal of Gastroenterology 109, no. 5 (2014): 769–770, 10.1038/ajg.2014.30. PubMed DOI
Vivas S., Ruiz de Morales J. M., Fernandez M., et al., “Age‐Related Clinical, Serological, and Histopathological Features of Celiac Disease,” American Journal of Gastroenterology 103, no. 9 (2008): 2360–2365: quiz 2366, 10.1111/j.1572-0241.2008.01977.x. PubMed DOI
Moreno M., “Celiac Disease in Children and Adolescents,” JAMA Pediatrics 168, no. 3 (2014): 300, 10.1001/jamapediatrics.2013.3331. PubMed DOI
Tanpowpong P., Broder‐Fingert S., Katz A. J., and Camargo C. A. Jr, “Age‐Related Patterns in Clinical Presentations and Gluten‐Related Issues Among Children and Adolescents With Celiac Disease,” Clinical and Translational Gastroenterology 3, no. 2 (2012): e9, 10.1038/ctg.2012.4. PubMed DOI PMC
Bianchi P. I., Lenti M. V., Petrucci C., et al., “Diagnostic Delay of Celiac Disease in Childhood,” JAMA Network Open 7, no. 4 (2024): e245671, 10.1001/jamanetworkopen.2024.5671. PubMed DOI PMC
Di Sabatino A. and Corazza G. R., “Coeliac Disease,” Lancet 373, no. 9673 (2009): 1480–1493, 10.1016/S0140-6736(09)60254-3. PubMed DOI
Riestra S., Domínguez F., Fernández‐Ruiz E., et al., “Usefulness of Duodenal Biopsy During Routine Upper Gastrointestinal Endoscopy for Diagnosis of Celiac Disease,” World Journal of Gastroenterology 12, no. 31 (2006): 5028–5032, 10.3748/wjg.v12.i31.5028. PubMed DOI PMC
Lau M. S., Mooney P., White W., et al., “Pre‐Endoscopy Point of Care Test (Simtomax‐ IgA/IgG‐Deamidated Gliadin Peptide) for Coeliac Disease in Iron Deficiency Anaemia: Diagnostic Accuracy and a Cost Saving Economic Model,” BMC Gastroenterology 16, no. 1 (2016): 115, 10.1186/s12876-016-0521-5. PubMed DOI PMC
Corazza G. R., Valentini R. A., Andreani M. L., et al., “Subclinical Coeliac Disease Is a Frequent Cause of Iron‐Deficiency Anaemia,” Scandinavian Journal of Gastroenterology 30, no. 2 (1995): 153–156, 10.3109/00365529509093254. PubMed DOI
Zamani F., Mohamadnejad M., Shakeri R., et al., “Gluten Sensitive Enteropathy in Patients With Iron Deficiency Anemia of Unknown Origin,” World Journal of Gastroenterology 14, no. 48 (2008): 7381–7385, 10.3748/wjg.14.7381. PubMed DOI PMC
Mahadev S., Laszkowska M., Sundström J., et al., “Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia‐A Systematic Review With Meta‐Analysis,” Gastroenterology 155, no. 2 (2018): 374–382.e1, 10.1053/j.gastro.2018.04.016. PubMed DOI PMC
Masjedizadeh R., Hajiani E., Hashemi J., Shayesteh A. A., Moula K., and Rajabi T., “Celiac Disease in South‐West of Iran,” World Journal of Gastroenterology 12, no. 27 (2006): 4416–4419, 10.3748/wjg.v12.i27.4416. PubMed DOI PMC
Catassi C., Kryszak D., Louis‐Jacques O., et al., “Detection of Celiac Disease in Primary Care: A Multicenter Case‐Finding Study in North America,” American Journal of Gastroenterology 102, no. 7 (2007): 1454–1460, 10.1111/j.1572-0241.2007.01173.x. PubMed DOI
Mahadev S., Laszkowska M., Sundström J., et al., “Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia‐A Systematic Review With Meta‐Analysis,” Gastroenterology 155, no. 2 (2018): 374–382.e1, 10.1053/j.gastro.2018.04.016. PubMed DOI PMC
Corazza G., Valentini R. A., Frisoni M., et al., “Gliadin Immune Reactivity Is Associated With Overt and Latent Enteropathy in Relatives of Celiac Patients,” Gastroenterology 103, no. 5 (1992): 1517–1522, 10.1016/0016-5085(92)91172-z. PubMed DOI
Farré C., Humbert P., Vilar P., et al., “Serological Markers and HLA‐DQ2 Haplotype Among First‐Degree Relatives of Celiac Patients. Catalonian Coeliac Disease Study Group,” Digestive Diseases and Sciences 44, no. 11 (1999): 2344–2349, 10.1023/a:1026685527228. PubMed DOI
Bottaro G., Cataldo F., Rotolo N., Spina M., and Corazza G. R., “The Clinical Pattern of Subclinical/Silent Celiac Disease: An Analysis on 1026 Consecutive Cases,” American Journal of Gastroenterology 94, no. 3 (1999): 691–696, 10.1111/j.1572-0241.1999.00938.x. PubMed DOI
Fasano A., Berti I., Gerarduzzi T., et al., “Prevalence of Celiac Disease in At‐Risk and Not‐At‐Risk Groups in the United States: A Large Multicenter Study,” Archives of Internal Medicine 163, no. 3 (2003): 286–292, 10.1001/archinte.163.3.286. PubMed DOI
Bardella M. T., Elli L., Velio P., Fredella C., Prampolini L., and Cesana B., “Silent Celiac Disease Is Frequent in the Siblings of Newly Diagnosed Celiac Patients,” Digestion 75, no. 4 (2007): 182–187, 10.1159/000107979. PubMed DOI
Singh P., Arora S., Lal S., Strand T. A., and Makharia G. K., “Celiac Disease in Women With Infertility: A Meta‐Analysis,” Journal of Clinical Gastroenterology 50, no. 1 (2016): 33–39, 10.1097/MCG.0000000000000285. PubMed DOI
Franzese A., Iafusco D., Spadaro R., et al., “Study‐Group on Diabetes of Italian Society of Pediatric Endocrinology and Diabetology. Potential Celiac Disease in Type 1 Diabetes: A Multicenter Study,” Diabetes Research and Clinical Practice 92, no. 1 (2011): 53–56, 10.1016/j.diabres.2010.12.028. PubMed DOI
Kylökäs A., Kaukinen K., Huhtala H., Collin P., Mäki M., and Kurppa K., “Type 1 and Type 2 Diabetes in Celiac Disease: Prevalence and Effect on Clinical and Histological Presentation,” BMC Gastroenterology 16, no. 1 (2016): 76, 10.1186/s12876-016-0488-2. PubMed DOI PMC
Craig M. E., Prinz N., Boyle C. T., et al., “Australasian Diabetes Data Network (ADDN); T1D Exchange Clinic Network (T1DX); National Paediatric Diabetes Audit (NPDA) and the Royal College of Paediatrics and Child Health; Prospective Diabetes Follow‐Up Registry (DPV) Initiative. Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents,” Diabetes Care 40, no. 8 (2017): 1034–1040, 10.2337/dc16-2508. PubMed DOI PMC
Taczanowska A., Schwandt A., Amed S., et al., “Celiac Disease in Children With Type 1 Diabetes Varies Around the World: An International, Cross‐Sectional Study of 57 375 Patients From the SWEET Registry,” Journal of Diabetes 13, no. 6 (2021): 448–457, 10.1111/1753-0407.13126. PubMed DOI
Birkenfeld S., Dreiher J., Weitzman D., and Cohen A. D., “Coeliac Disease Associated With Psoriasis,” British Journal of Dermatology 161, no. 6 (2009): 1331–1334, 10.1111/j.1365-2133.2009.09398.x. PubMed DOI
De Bastiani R., Gabrielli M., Lora L., et al., “Association Between Coeliac Disease and Psoriasis: Italian Primary Care Multicentre Study,” Dermatology 230, no. 2 (2015): 156–160, 10.1159/000369615. PubMed DOI
Shalom G., Kridin K., Raviv K. O., et al., “Atopic Dermatitis and Celiac Disease: A Cross‐Sectional Study of 116,816 Patients,” American Journal of Clinical Dermatology 21, no. 1 (2020): 133–138, 10.1007/s40257-019-00474-2. PubMed DOI
Karakan T., Ozyemisci‐Taskiran O., Gunendi Z., Atalay F., and Tuncer C., “Prevalence of IgA‐Antiendomysial Antibody in a Patient Cohort With Idiopathic Low Bone Mineral Density,” World Journal of Gastroenterology 13, no. 21 (2007): 2978–2982, 10.3748/wjg.v13.i21.2978. PubMed DOI PMC
Sainsbury A., Sanders D. S., and Ford A. C., “Meta‐Analysis: Coeliac Disease and Hypertransaminasaemia,” Alimentary Pharmacology & Therapeutics 34, no. 1 (2011): 33–40, 10.1111/j.1365-2036.2011.04685.x. PubMed DOI
Mirzaagha F., Azali S. H., Islami F., et al., “Coeliac Disease in Autoimmune Liver Disease: A Cross‐Sectional Study and a Systematic Review,” Digestive and Liver Disease 42, no. 9 (2010): 620–623, 10.1016/j.dld.2010.02.006. PubMed DOI
Haggård L., Glimberg I., Lebwohl B., et al. F., “High Prevalence of Celiac Disease in Autoimmune Hepatitis: Systematic Review and Meta‐Analysis,” Liver International 41, no. 11 (2021): 2693–2702, 10.1111/liv.15000. PubMed DOI
Miceli E., Lenti M. V., Padula D., et al., “Common Features of Patients With Autoimmune Atrophic Gastritis,” Clinical Gastroenterology and Hepatology 10, no. 7 (2012): 812–814, 10.1016/j.cgh.2012.02.018. PubMed DOI
Lenti M. V., Miceli E., Cococcia S., et al., “Determinants of Diagnostic Delay in Autoimmune Atrophic Gastritis,” Alimentary Pharmacology & Therapeutics 50, no. 2 (2019): 167–175, 10.1111/apt.15317. PubMed DOI
Miceli E., Vanoli A., Lenti M. V., et al., “Natural History of Autoimmune Atrophic Gastritis: A Prospective, Single Centre, Long‐Term Experience,” Alimentary Pharmacology & Therapeutics 50, no. 11‐12 (2019): 1172–1180, 10.1111/apt.15540. PubMed DOI
Lenti M. V., Lahner E., Bergamaschi G., et al., “Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study,” Journal of Clinical Medicine 8, no. 11 (2019): 1992, 10.3390/jcm8111992. PubMed DOI PMC
Lenti M. V., Rugge M., Lahner E., et al., “Autoimmune Gastritis,” Nature Reviews Disease Primers 6, no. 1 (2020): 56, 10.1038/s41572-020-0187-8. PubMed DOI
Miceli E., Lenti M. V., Gentile A., et al., “Long‐Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric Series,” American Journal of Gastroenterology 119, no. 5 (2024): 837–845, 10.14309/ajg.0000000000002619. PubMed DOI
Lenti M. V., Miceli E., Lahner E., et al., “Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti‐Parietal Cell Antibodies: Results From the Autoimmune GastRitis Italian NetwOrk Study grOup (ARIOSO),” American Journal of Gastroenterology 119, no. 12 (2024): 2408–2417, 10.14309/ajg.0000000000002948. PubMed DOI
Miceli E., Padula D., Lenti M. V., et al., “A Laboratory Score in the Diagnosis of Autoimmune Atrophic Gastritis: A Prospective Study,” Journal of Clinical Gastroenterology 49, no. 1 (2015 Jan): e1–e5, 10.1097/MCG.0000000000000101. PubMed DOI
Di S. A., Biagi F., Lenzi M., et al., “Clinical Usefulness of Serum Antibodies as Biomarkers of Gastrointestinal and Liver Diseases,” Digestive and Liver Disease 49, no. 9 (2017): 947–956, 10.1016/j.dld.2017.06.010. PubMed DOI
Lenti M. V., Miceli E., Padula D., et al., “Infertility and Recurrent Miscarriage in a Patient With Autoimmune Atrophic Gastritis,” Internal and Emergency Medicine 13, no. 5 (2018): 815–816, 10.1007/s11739-018-1823-0. PubMed DOI
Lenti M. V., Cococcia S., Miceli E., et al., “Red Flags for the Diagnosis of Autoimmune Gastritis,” Clinics and Research in Hepatology and Gastroenterolog 46, no. 1 (2022): 101780, 10.1016/j.clinre.2021.101780. PubMed DOI
Lenti M. V., Miceli E., Joudaki S., Gentile A., and Di Sabatino A., and Autoimmune Gastritis Team , “Impact of an Active Case‐Finding Strategy in Autoimmune Gastritis,” European Journal of Internal Medicine 130 (2024 Jul 16): 179–181, 10.1016/j.ejim.2024.07.011. PubMed DOI
Mottacki N., Simrén M., and Bajor A., “Review Article: Bile Acid Diarrhoea ‐ Pathogenesis, Diagnosis and Management,” Alimentary Pharmacology & Therapeutics 43, no. 8 (2016): 884–898, 10.1111/apt.13570. PubMed DOI
Kurien M., Evans K. E., Leeds J. S., Hopper A. D., Harris A., and Sanders D. S., “Bile Acid Malabsorption: An Under‐investigated Differential Diagnosis in Patients Presenting With Diarrhea Predominant Irritable Bowel Syndrome Type Symptoms,” Scandinavian Journal of Gastroenterology 46, no. 7‐8 (2011): 818–822, 10.3109/00365521.2011.574728. PubMed DOI
Gracie D. J., Kane J. S., Mumtaz S., Scarsbrook A. F., Chowdhury F. U., and Ford A. C., “Prevalence of, and Predictors of, Bile Acid Malabsorption in Outpatients With Chronic Diarrhea,” Neuro‐Gastroenterology and Motility 24, no. 11 (2012): 983‐e538, 10.1111/j.1365-2982.2012.01953.x. PubMed DOI
Shiha M. G., Ashgar Z., Fraser E. M., Kurien M., and Aziz I., “High Prevalence of Primary Bile Acid Diarrhoea in Patients With Functional Diarrhoea and Irritable Bowel Syndrome‐Diarrhoea, Based on Rome III and Rome IV Criteria,” EClinicalMedicine 25 (2020): 100465, 10.1016/j.eclinm.2020.100465. PubMed DOI PMC
Aziz I., Mumtaz S., Bholah H., Chowdhury F. U., Sanders D. S., and Ford A. C., “High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea‐Predominant Irritable Bowel Syndrome Based on Rome III Criteria,” Clinical Gastroenterology and Hepatology 13, no. 9 (2015): 1650–1655.e2, 10.1016/j.cgh.2015.03.002. PubMed DOI
Slattery S. A., Niaz O., Aziz Q., Ford A. C., and Farmer A. D., “Systematic Review With Meta‐Analysis: The Prevalence of Bile Acid Malabsorption in the Irritable Bowel Syndrome With Diarrhoea,” Alimentary Pharmacology & Therapeutics 42, no. 1 (2015): 3–11, 10.1111/apt.13227. PubMed DOI
Campbell J. A., Sanders D. S., Francis K. A., et al., “Should We Investigate Gastroenterology Patients for Pancreatic Exocrine Insufficiency? A Dual Centre UK Study,” Journal of Gastrointestinal and Liver Diseases 25, no. 3 (2016): 303–309, 10.15403/jgld.2014.1121.253.uks. PubMed DOI
Rault A., SaCunha A., Klopfenstein D., et al., “Pancreaticojejunal Anastomosis Is Preferable to Pancreaticogastrostomy After Pancreaticoduodenectomy for Longterm Outcomes of Pancreatic Exocrine Function,” Journal of the American College of Surgeons 201, no. 2 (2005): 239–244, 10.1016/j.jamcollsurg.2005.03.026. PubMed DOI
Malfertheiner P., Ripellino C., and Cataldo N., “Severe Intestinal Malabsorption Associated With ACE Inhibitor or Angiotensin Receptor Blocker Treatment. An Observational Cohort Study in Germany and Italy,” Pharmacoepidemiology and Drug Safety 27, no. 6 (2018): 581–586, 10.1002/pds.4402. PubMed DOI PMC
Schiepatti A., Minerba P., Puricelli M., et al., “Systematic Review: Clinical Phenotypes, Histopathological Features and Prognosis of Enteropathy Due to Angiotensin II Receptor Blockers,” Alimentary Pharmacology & Therapeutics 59, no. 4 (2024): 432–444, 10.1111/apt.17855. PubMed DOI
Khandakar B. and Srivastava A., “Immune Checkpoint Inhibitor Therapy Associated Enteritis Mimicking Celiac Disease,” Gastroenterol Hepatol Bed Bench. 16, no. 2 (2023): 240–244, 10.22037/ghfbb.v16i2.2855. PubMed DOI PMC
Schiepatti A., Premoli A., Maimaris S., et al., “Small Bowel Villous Atrophy Due to Immune‐Checkpoint Inhibitors: Report of Two Cases and Literature Review,” Drugs In Context 11 (2022): 2022‐6‐3, 10.7573/dic.2022-6-3. PubMed DOI PMC
Lenti M. V., Ribaldone D. G., Borrelli de Andreis F., et al., “European Consortium for the Study of Immune Checkpoint Inhibitor‐Induced Colitis. A 1‐Year Follow‐Up Study on Checkpoint Inhibitor‐Induced Colitis: Results From a European Consortium,” ESMO Open 9, no. 7 (2024): 103632, 10.1016/j.esmoop.2024.103632. PubMed DOI PMC
Letschert J. G., Lebesque J. V., Aleman B. M., et al., “The Volume Effect in Radiation‐Related Late Small Bowel Complications: Results of a Clinical Study of the EORTC Radiotherapy Cooperative Group in Patients Treated for Rectal Carcinoma,” Radiotherapy & Oncology 32, no. 2 (1994): 116–123, 10.1016/0167-8140(94)90097-3. PubMed DOI
Andreyev H. J., Vlavianos P., Blake P., Dearnaley D., Norman A. R., and Tait D., “Gastrointestinal Symptoms After Pelvic Radiotherapy: Role for the Gastroenterologist?,” International Journal of Radiation Oncology, Biology, Physics 62, no. 5 (2005): 1464–1471, 10.1016/j.ijrobp.2004.12.087. PubMed DOI
Homan G. J., “Failure to Thrive: A Practical Guide,” American Family Physician 94, no. 4 (2016): 295–299. PubMed
Husby S., Koletzko S., Korponay‐Szabó I., et al., “European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020,” Journal of Pediatric Gastroenterology and Nutrition 70, no. 1 (2020): 141–156, 10.1097/MPG.0000000000002497. PubMed DOI
Bischoff S. C., Escher J., Hébuterne X., et al., “ESPEN Practical Guideline: Clinical Nutrition in Inflammatory Bowel Disease,” Clinical Nutrition 39, no. 3 (2020): 632–653, 10.1016/j.clnu.2019.11.002. PubMed DOI
Mouzaki M., Bronsky J., Gupte G., et al., “Nutrition Support of Children With Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition,” Journal of Pediatric Gastroenterology and Nutrition 69, no. 4 (2019): 498–511, 10.1097/MPG.0000000000002443. PubMed DOI
Gray M. and Duggan C. P., “3.10 Intestinal Failure and Malabsorption,” World Review of Nutrition & Dietetics 124 (2022): 285–290, 10.1159/000516725. PubMed DOI
Roberts S. E., Morrison‐Rees S., Thapar N., et al., “Systematic Review and Meta‐Analysis: The Incidence and Prevalence of Paediatric Coeliac Disease Across Europe,” Alimentary Pharmacology & Therapeutics 54, no. 2 (2021): 109–128, 10.1111/apt.16337. PubMed DOI
Green P. H., Rostami K., and Marsh M. N., “Diagnosis of Coeliac Disease,” Best Practice & Research Clinical Gastroenterology 19, no. 3 (2005): 389–400, 10.1016/j.bpg.2005.02.006. PubMed DOI
Cristofori F., Fontana C., Magistà A., et al., “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome: A 6‐year Prospective Cohort Study,” JAMA Pediatrics 168, no. 6 (2014): 555–560, 10.1001/jamapediatrics.2013.4984. PubMed DOI
Werkstetter K. J., Korponay‐Szabó I. R., Popp A., et al., “Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice,” Gastroenterology 153, no. 4 (2017): 924–935, 10.1053/j.gastro.2017.06.002. PubMed DOI
Khatib M., Baker R. D., Ly E. K., Kozielski R., and Baker S. S., “Presenting Pattern of Pediatric Celiac Disease,” Journal of Pediatric Gastroenterology and Nutrition 62, no. 1 (2016): 60–63, 10.1097/MPG.0000000000000887. PubMed DOI
Kurppa K., Laitinen A., and Agardh D., “Coeliac Disease in Children With Type 1 Diabetes,” Lancet Child Adolesc Health 2, no. 2 (2018): 133–143, 10.1016/S2352-4642(17)30172-4. PubMed DOI
Malik V. S., Schulze M. B., and Hu F. B., “Intake of Sugar‐Sweetened Beverages and Weight Gain: A Systematic Review,” American Journal of Clinical Nutrition 84, no. 2 (2006): 274–288, 10.1093/ajcn/84.1.274. PubMed DOI PMC
Hammer J., Memaran N., Huber W. D., and Hammer K., “Development and Validation of the Paediatric Carbohydrate Perception Questionnaire (pCPQ), an Instrument for the Assessment of Carbohydrate‐Induced Gastrointestinal Symptoms in the Paediatric Population,” Neuro‐Gastroenterology and Motility 32, no. 12 (2020): e13934, 10.1111/nmo.13934. PubMed DOI PMC
Berni C. R., Pezzella V., Amoroso A., Cozzolino T., Di Scala C., and Passariello A., “Diagnosing and Treating Intolerance to Carbohydrates in Children,” Nutrients 8, no. 3 (2016): 157, 10.3390/nu8030157. PubMed DOI PMC
Hammer H. F., Santa A. C. A., Schiller L. R., and Fordtran J. S., “Studies of Osmotic Diarrhea Induced in Normal Subjects by Ingestion of Polyethylene Glycol and Lactulose,” Journal of Clinical Investigation 84, no. 4 (1989): 1056–1062, 10.1172/JCI114267. PubMed DOI PMC
Hammer H. F., Fine K. D., Santa Ana C. A., Porter J. L., Schiller L. R., and Fordtran J. S., “Carbohydrate Malabsorption. Its Measurement and its Contribution to Diarrhea,” Journal of Clinical Investigation 86, no. 6 (1990): 1936–1944, 10.1172/JCI114927. PubMed DOI PMC
Hammer H. F. and Sheikh M. S., “Colonic Gas Excretion in Induced Carbohydrate Malabsorption–Effect of Simethicone,” European Journal of Gastroenterology and Hepatology 4 (1992): 141–145.
Hammer H. F., “Colonic Hydrogen Absorption: Quantification of its Effect on Hydrogen Accumulation Caused by Bacterial Fermentation of Carbohydrates,” Gut 34, no. 6 (1993): 818–822, 10.1136/gut.34.6.818. PubMed DOI PMC
Campbell A. K., Matthews S. B., Vassel N., et al., “Bacterial Metabolic ‘toxins’: A New Mechanism for Lactose and Food Intolerance, and Irritable Bowel Syndrome,” Toxicology 278, no. 3 (2010): 268–276, 10.1016/j.tox.2010.09.001. PubMed DOI
Heyman M. B., “Committee on Nutrition. Lactose Intolerance in Infants, Children, and Adolescents,” Pediatrics 118, no. 3 (2006): 1279–1286, 10.1542/peds.2006-1721. PubMed DOI
Wright E. M., Martín M. G., and Turk E., “Intestinal Absorption in Health and Disease‐‐Sugars,” Best Practice & Research Clinical Gastroenterology 17, no. 6 (2003): 943–956, 10.1016/s1521-6918(03)00107-0. PubMed DOI
Uhrich S., Wu Z., Huang J. Y., and Scott C. R., “Four Mutations in the SI Gene Are Responsible for the Majority of Clinical Symptoms of CSID,” Journal of Pediatric Gastroenterology and Nutrition 55, no. Suppl 2 (2012): S34–S35, 10.1097/01.mpg.0000421408.65257.b5. PubMed DOI
Högenauer C., Hammer H. F., Mellitzer K., Renner W., Krejs G. J., and Toplak H., “Evaluation of a New DNA Test Compared With the Lactose Hydrogen Breath Test for the Diagnosis of Lactase Non‐Persistence,” European Journal of Gastroenterology and Hepatology 17, no. 3 (2005): 371–376, 10.1097/00042737-200503000-00018. PubMed DOI
Broekaert I. J., Borrelli O., Dolinsek J., et al., “An ESPGHAN Position Paper on the Use of Breath Testing in Paediatric Gastroenterology,” Journal of Pediatric Gastroenterology and Nutrition 74, no. 1 (2022): 123–137, 10.1097/MPG.0000000000003245. PubMed DOI
Klare C., Hammer J., and Hammer H. F., “The Adult Carbohydrate Perception Questionnaire Identifies Patients With Lactose or Fructose Intolerance Who Respond to Diet,” Digestive Diseases 42, no. 3 (2024): 276–284, 10.1159/000538419. PubMed DOI
Hammer H. F., Fox M. R., Keller J., et al., “European Guideline on Indications, Performance, and Clinical Impact of Hydrogen and Methane Breath Tests in Adult and Pediatric Patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition Consensus,” United European Gastroenterol J 10, no. 1 (2022): 15–40, 10.1002/ueg2.12133. PubMed DOI PMC
Wang W., Wang L., and Ma M., “Literature Review on Congenital Glucose‐Galactose Malabsorption From 2001 to 2019,” Journal of Paediatrics and Child Health 56, no. 11 (2020): 1779–1784, 10.1111/jpc.14702. PubMed DOI
Hammer V., Hammer K., Memaran N., Huber W. D., Hammer K., and Hammer J., “Relationship Between Abdominal Symptoms and Fructose Ingestion in Children With Chronic Abdominal Pain,” Digestive Diseases and Sciences 63, no. 5 (2018): 1270–1279, 10.1007/s10620-018-4997-4. PubMed DOI PMC
Hammer K. and Hammer J., “Valid Assessment of Carbohydrate Intolerance and the Need for a Distinction to Carbohydrate Malabsorption. Comment on Roles of Lactose and Fructose Malabsorption and Dietary Outcomes in Children Presenting With Chronic Abdominal Pain,” Nutrients 12, no. 6 (2019): 1546, 10.3390/nu12061546. PubMed DOI PMC
Komericki P., Akkilic‐Materna M., Strimitzer T., Weyermair K., Hammer H. F., and Aberer W., “Oral Xylose Isomerase Decreases Breath Hydrogen Excretion and Improves Gastrointestinal Symptoms in Fructose Malabsorption ‐ A Double‐Blind, Placebo‐Controlled Study,” Alimentary Pharmacology & Therapeutics 36, no. 10 (2012): 980–987, 10.1111/apt.12057. PubMed DOI
Diéguez‐Castillo C., Jiménez‐Luna C., Prados J., Martín‐Ruiz J. L., and Caba O., “State of the Art in Exocrine Pancreatic Insufficiency,” Medicina (Kaunas) 56, no. 10 (2020): 523, 10.3390/medicina56100523. PubMed DOI PMC
Brownell J. N., Bashaw H., and Stallings V. A., “Growth and Nutrition in Cystic Fibrosis,” Seminars in Respiratory and Critical Care Medicine 40, no. 6 (2019): 775–791, 10.1055/s-0039-1696726. PubMed DOI
Abu‐El‐Haija M., Uc A., Werlin S. L., et al., “Nutritional Considerations in Pediatric Pancreatitis: A Position Paper From the NASPGHAN Pancreas Committee and ESPGHAN Cystic Fibrosis/Pancreas Working Group,” Journal of Pediatric Gastroenterology and Nutrition 67, no. 1 (2018): 131–143, 10.1097/MPG.0000000000002023. PubMed DOI PMC
Taylor C. J., Chen K., Horvath K., et al., “ESPGHAN and NASPGHAN Report on the Assessment of Exocrine Pancreatic Function and Pancreatitis in Children,” Journal of Pediatric Gastroenterology and Nutrition 61, no. 1 (2015): 144–153, 10.1097/MPG.0000000000000830. PubMed DOI
Goulet O., Ruemmele F., Lacaille F., and Colomb V., “Irreversible Intestinal Failure,” Journal of Pediatric Gastroenterology and Nutrition 38, no. 3 (2004): 250–269, 10.1097/00005176-200403000-00006. PubMed DOI
Duggan C. P. and Jaksic T., “Pediatric Intestinal Failure,” New England Journal of Medicine 377, no. 7 (2017): 666–675, 10.1056/NEJMra1602650. PubMed DOI
Thapar N., Saliakellis E., Benninga M. A., et al., “Paediatric Intestinal Pseudo‐Obstruction: Evidence and Consensus‐Based Recommendations From an ESPGHAN‐Led Expert Group,” Journal of Pediatric Gastroenterology and Nutrition 66, no. 6 (2018): 991–1019, 10.1097/MPG.0000000000001982. PubMed DOI
Chandra R. and Kesavan A., “Current Treatment Paradigms in Pediatric Short Bowel Syndrome,” Clin J Gastroenterol 11, no. 2 (2018): 103–112, 10.1007/s12328-017-0811-7. PubMed DOI
DeLegge M., Delegge M., Wooley J. A., et al., “A.S.P.E.N. Board of Directors. The State of Nutrition Support Teams and Update on Current Models for Providing Nutrition Support Therapy to Patients,” Nutrition in Clinical Practice 25, no. 1 (2010): 76–84, 10.1177/0884533609354901. PubMed DOI
Andorsky D. J., Lund D. P., Lillehei C. W., et al., “Nutritional and Other Postoperative Management of Neonates With Short Bowel Syndrome Correlates With Clinical Outcomes,” Jornal de Pediatria 139, no. 1 (2001): 27–33, 10.1067/mpd.2001.114481. PubMed DOI
Miele E., Shamir R., Aloi M., et al., “Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition,” Journal of Pediatric Gastroenterology and Nutrition 66, no. 4 (2018): 687–708, 10.1097/MPG.0000000000001896. PubMed DOI
Vasseur F., Gower‐Rousseau C., Vernier‐Massouille G., et al., “Nutritional Status and Growth in Pediatric Crohn's Disease: A Population‐Based Study,” American Journal of Gastroenterology 105, no. 8 (2010): 1893–1900, 10.1038/ajg.2010.20. PubMed DOI
Heuschkel R., Salvestrini C., Beattie R. M., Hildebrand H., Walters T., and Griffiths A., “Guidelines for the Management of Growth Failure in Childhood Inflammatory Bowel Disease,” Inflammatory Bowel Diseases 14, no. 6 (2008): 839–849, 10.1002/ibd.20378. PubMed DOI
Steiner S. J., Noe J. D., and Denne S. C., “Corticosteroids Increase Protein Breakdown and Loss in Newly Diagnosed Pediatric Crohn Disease,” Pediatric Research 70, no. 5 (2011): 484–488, 10.1203/PDR.0b013e31822f5886. PubMed DOI
Hannon T. S., Dimeglio L. A., Pfefferkorn M. D., and Denne S. C., “Acute Effects of Enteral Nutrition on Protein Turnover in Adolescents With Crohn Disease,” Pediatric Research 61, no. 3 (2007): 356–360, 10.1203/pdr.0b013e318030d11c. PubMed DOI
van Rheenen P. F., Aloi M., Assa A., et al., “The Medical Management of Paediatric Crohn's Disease: An ECCO‐ESPGHAN Guideline Update,” Journal of Crohn's and Colitis 15, no. 2 (2020): jjaa161–194, 10.1093/ecco-jcc/jjaa161. PubMed DOI
Lopes L. H., Sdepanian V. L., Szejnfeld V. L., de Morais M. B., and Fagundes‐Neto U., “Risk Factors for Low Bone Mineral Density in Children and Adolescents With Inflammatory Bowel Disease,” Digestive Diseases and Sciences 53, no. 10 (2008): 2746–2753, 10.1007/s10620-008-0223-0. PubMed DOI
Dziechciarz P., Horvath A., Shamir R., and Szajewska H., “Meta‐Analysis: Enteral Nutrition in Active Crohn's Disease in Children,” Alimentary Pharmacology & Therapeutics 26, no. 6 (2007): 795–806, 10.1111/j.1365-2036.2007.03431.x. PubMed DOI
Akobeng A. K. and Thomas A. G., “Refeeding Syndrome Following Exclusive Enteral Nutritional Treatment in Crohn Disease,” Journal of Pediatric Gastroenterology and Nutrition 51, no. 3 (2010): 364–366, 10.1097/MPG.0b013e3181e712d6. PubMed DOI
Socha P., Koletzko B., Swiatkowska E., Pawlowska J., Stolarczyk A., and Socha J., “Essential Fatty Acid Metabolism in Infants With Cholestasis,” Acta Paediatrica 87, no. 3 (1998): 278–283, 10.1080/08035259850157327. PubMed DOI
Bettler J. and Roberts K. E., “Nutrition Assessment of the Critically Ill Child,” AACN Clinical Issues 11, no. 4 (2000): 498–506, 10.1097/00044067-200011000-00003. PubMed DOI
Pettei M. J., Daftary S., and Levine J. J., “Essential Fatty Acid Deficiency Associated With the Use of a Medium‐Chain‐Triglyceride Infant Formula in Pediatric Hepatobiliary Disease,” American Journal of Clinical Nutrition 53, no. 5 (1991): 1217–1221, 10.1093/ajcn/53.5.1217. PubMed DOI
Corazza G. R., Frazzoni M., Gatto M. R., and Gasbarrini G., “Ageing and Small‐Bowel Mucosa: A Morphometric Study,” Gerontology 32, no. 1 (1986): 60–65, 10.1159/000212766. PubMed DOI
Pénzes L., “Intestinal Response in Aging: Changes in Reserve Capacity,” Acta Medica Hungarica 41, no. 4 (1984): 263–277. PubMed
Woudstra T. and Thomson A. B., “Nutrient Absorption and Intestinal Adaptation With Ageing,” Best Practice & Research Clinical Gastroenterology 16, no. 1 (2002): 1–15, 10.1053/bega.2001.0262. PubMed DOI
Bolin T., Bare M., Caplan G., Daniells S., and Holyday M., “Malabsorption May Contribute to Malnutrition in the Elderly,” Nutrition 26, no. 7‐8 (2010): 852–853, 10.1016/j.nut.2009.11.016. PubMed DOI
Thomson A. B., “Small Intestinal Disorders in the Elderly,” Best Practice & Research Clinical Gastroenterology 23, no. 6 (2009): 861–874, 10.1016/j.bpg.2009.10.009. PubMed DOI
Schiller L. R., “Maldigestion Versus Malabsorption in the Elderly,” Current Gastroenterology Reports 22, no. 7 (2020): 33, 10.1007/s11894-020-00771-5. PubMed DOI
Di Stefano M., Veneto G., Malservisi S., Strocchi A., and Corazza G. R., “Lactose Malabsorption and Intolerance in the Elderly,” Scandinavian Journal of Gastroenterology 36, no. 12 (2001): 1274–1278, 10.1080/003655201317097119. PubMed DOI
Almeida J. A., Kim R., Stoita A., McIver C. J., Kurtovic J., and Riordan S. M., “Lactose Malabsorption in the Elderly: Role of Small Intestinal Bacterial Overgrowth,” Scandinavian Journal of Gastroenterology 43, no. 2 (2008): 146–154, 10.1080/00365520701676617. PubMed DOI
D'Souza A. L., “Ageing and the Gut,” Postgraduate Medical Journal 83, no. 975 (2007): 44–53, 10.1136/pgmj.2006.049361. PubMed DOI PMC
Hoffmann J. C. and Zeitz M., “Small Bowel Disease in the Elderly: Diarrhoea and Malabsorption,” Best Practice & Research Clinical Gastroenterology 16, no. 1 (2002): 17–36, 10.1053/bega.2002.0263. PubMed DOI
Allen L. H., “How Common Is Vitamin B‐12 Deficiency?,” American Journal of Clinical Nutrition 89, no. 2 (2009): 693S–696S, 10.3945/ajcn.2008.26947A. PubMed DOI
Wong C. W., “Vitamin B12 Deficiency in the Elderly: Is it Worth Screening?,” Hong Kong Medical Journal 21, no. 2 (2015): 155–164, 10.12809/hkmj144383. PubMed DOI
Carmel R., “Cobalamin, the Stomach, and Aging,” American Journal of Clinical Nutrition 66, no. 4 (1997): 750–759, 10.1093/ajcn/66.4.750. PubMed DOI
Ho C., Kauwell G. P., and Bailey L. B., “Practitioners' Guide to Meeting the Vitamin B‐12 Recommended Dietary Allowance for People Aged 51 Years and Older,” Journal of the American Dietetic Association 99, no. 6 (1999): 725–727, 10.1016/S0002-8223(99)00174-1. PubMed DOI
Holt P. R., “Intestinal Malabsorption in the Elderly,” Digestive Diseases 25, no. 2 (2007): 144–150, 10.1159/000099479. PubMed DOI
Andrès E., Loukili N. H., Noel E., et al., “Vitamin B12 (Cobalamin) Deficiency in Elderly Patients,” Canadian Medical Association Journal 171, no. 3 (2004): 251–259, 10.1503/cmaj.1031155. PubMed DOI PMC
Bhutto A. and Morley J. E., “The Clinical Significance of Gastrointestinal Changes With Aging,” Current Opinion in Clinical Nutrition and Metabolic Care 11, no. 5 (2008): 651–660, 10.1097/MCO.0b013e32830b5d37. PubMed DOI
Andrès E., Federici L., Serraj K., and Kaltenbach G., “Update of Nutrient‐Deficiency Anemia in Elderly Patients,” European Journal of Internal Medicine 19, no. 7 (2008): 488–493, 10.1016/j.ejim.2008.01.016. PubMed DOI
Sipponen P., Laxén F., Huotari K., and Härkönen M., “Prevalence of Low Vitamin B12 and High Homocysteine in Serum in an Elderly Male Population: Association With Atrophic Gastritis and Helicobacter Pylori Infection,” Scandinavian Journal of Gastroenterology 38, no. 12 (2003): 1209–1216, 10.1080/00365520310007224. PubMed DOI
Bradford G. S. and Taylor C. T., “Omeprazole and Vitamin B12 Deficiency,” Annals of Pharmacotherapy 33, no. 5 (1999): 641–643, 10.1345/aph.18199. PubMed DOI
Thorens J., Froehlich F., Schwizer W., et al., “Bacterial Overgrowth During Treatment With Omeprazole Compared With Cimetidine: A Prospective Randomised Double Blind Study,” Gut 39, no. 1 (1996): 54–59, 10.1136/gut.39.1.54. PubMed DOI PMC
Lam J. R., Schneider J. L., Zhao W., and Corley D. A., “Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency,” JAMA 310, no. 22 (2013): 2435–2442, 10.1001/jama.2013.280490. PubMed DOI
Delport R., “Hyperhomocyst(e)inemia, Related Vitamins and Dementias,” Journal of Nutrition, Health & Aging 4, no. 4 (2000): 195–196. PubMed
Andrès E., Affenberger S., Vinzio S., et al., “Food‐cobalamin Malabsorption in Elderly Patients: Clinical Manifestations and Treatment,” Americas Journal of Medicine 118, no. 10 (2005): 1154–1159, 10.1016/j.amjmed.2005.02.026. PubMed DOI
Rosenberg I. H., Bowman B. B., Cooper B. A., Halsted C. H., and Lindenbaum J., “Folate Nutrition in the Elderly,” American Journal of Clinical Nutrition 36, no. 5 Suppl (1982): 1060–1066, 10.1093/ajcn/36.5.1060. PubMed DOI
Araújo J. R., Martel F., Borges N., Araújo J. M., and Keating E., “Folates and Aging: Role in Mild Cognitive Impairment, Dementia and Depression,” Ageing Research Reviews 22 (2015): 9–19, 10.1016/j.arr.2015.04.005. PubMed DOI
Devlieger R., Guelinckx I., Jans G., Voets W., Vanholsbeke C., and Vansant G., “Micronutrient Levels and Supplement Intake in Pregnancy After Bariatric Surgery: A Prospective Cohort Study,” PLoS One 9, no. 12 (2014): e114192, 10.1371/journal.pone.0114192. PubMed DOI PMC
Rozanska‐Waledziak A., Kacperczyk‐Bartnik J., Waledziak M., et al., “Intrauterine Growth Retardation After Laparoscopic Roux‐En‐Y Gastric Bypass ‐ Clinical Presentation and Literature Review,” Ginekologia Polska 92, no. 3 (2021): 226–229, 10.5603/GP.a2020.0163. PubMed DOI
González I., Rubio M. A., Cordido F., et al., “Maternal and Perinatal Outcomes After Bariatric Surgery: A Spanish Multicenter Study,” Obesity Surgery 25, no. 3 (2015): 436–442, 10.1007/s11695-014-1387-7. PubMed DOI
Akhter Z., Rankin J., Ceulemans D., et al., “Pregnancy After Bariatric Surgery and Adverse Perinatal Outcomes: A Systematic Review and Meta‐Analysis,” PLoS Medicine 16, no. 8 (2019): e1002866, 10.1371/journal.pmed.1002866. PubMed DOI PMC
Chevrot A., Kayem G., Coupaye M., Lesage N., Msika S., and Mandelbrot L., “Impact of Bariatric Surgery on Fetal Growth Restriction: Experience of a Perinatal and Bariatric Surgery Center,” American Journal of Obstetrics and Gynecology 214, no. 5 (2016): 655.e1–657.e1, 10.1016/j.ajog.2015.11.017. PubMed DOI
Bala R., Verma R., Verma P., et al., “Hyperhomocysteinemia and Low Vitamin B12 Are Associated With the Risk of Early Pregnancy Loss: A Clinical Study and Meta‐Analyses,” Nutrition Research 91 (2021): 57–66, 10.1016/j.nutres.2021.05.002. PubMed DOI
Di Simone N., Gratta M., Castellani R., et al., “Celiac Disease and Reproductive Failures: An Update on Pathogenic Mechanisms,” American Journal of Reproductive Immunology 85, no. 4 (2021): e13334, 10.1111/aji.13334. PubMed DOI
Tersigni C., Castellani R., de Waure C., et al., “Celiac Disease and Reproductive Disorders: Meta‐Analysis of Epidemiologic Associations and Potential Pathogenic Mechanisms,” Human Reproduction Update 20, no. 4 (2014): 582–593, 10.1093/humupd/dmu007. PubMed DOI
Saccone G., Berghella V., Sarno L., et al., “Celiac Disease and Obstetric Complications: A Systematic Review and Metaanalysis,” American Journal of Obstetrics and Gynecology 214, no. 2 (2016): 225–234, 10.1016/j.ajog.2015.09.080. PubMed DOI
Kiefte‐de Jong J. C., Jaddoe V. W., Uitterlinden A. G., et al., “Levels of Antibodies Against Tissue Transglutaminase During Pregnancy Are Associated With Reduced Fetal Weight and Birth Weight,” Gastroenterology 144, no. 4 (2013): 726–735.e2, 10.1053/j.gastro.2013.01.003. PubMed DOI
Martinelli D., Fortunato F., Tafuri S., Germinario C. A., and Prato R., “Reproductive Life Disorders in Italian Celiac Women. A Case‐Control Study,” BMC Gastroenterology 10, no. 1 (2010): 89, 10.1186/1471-230X-10-89. PubMed DOI PMC
Sheiner E., Peleg R., and Levy A., “Pregnancy Outcome of Patients With Known Celiac Disease,” European Journal of Obstetrics & Gynecology and Reproductive Biology 129, no. 1 (2006): 41–45, 10.1016/j.ejogrb.2005.10.023. PubMed DOI
Bustos D., Moret A., Tambutti M., et al., “Autoantibodies in Argentine Women With Recurrent Pregnancy Loss,” American Journal of Reproductive Immunology 55, no. 3 (2006): 201–207, 10.1111/j.1600-0897.2005.00349.x. PubMed DOI
Tursi A., Giorgetti G., Brandimarte G., and Elisei W., “Effect of Gluten‐Free Diet on Pregnancy Outcome in Celiac Disease Patients With Recurrent Miscarriages,” Digestive Diseases and Sciences 53, no. 11 (2008): 2925–2928, 10.1007/s10620-008-0242-x. PubMed DOI
Ludvigsson J. F., Montgomery S. M., and Ekbom A., “Celiac Disease and Risk of Adverse Fetal Outcome: A Population‐Based Cohort Study,” Gastroenterology 129, no. 2 (2005): 454–463, 10.1016/j.gastro.2005.05.065. PubMed DOI
Stazi A. V. and Mantovani A., “A Risk Factor for Female Fertility and Pregnancy: Celiac Disease,” Gynecological Endocrinology 14, no. 6 (2000): 454–463, 10.3109/09513590009167719. PubMed DOI
Smecuol E., Mauriño E., Vazquez H., et al., “Gynaecological and Obstetric Disorders in Coeliac Disease: Frequent Clinical Onset During Pregnancy or the Puerperium,” European Journal of Gastroenterology and Hepatology 8, no. 1 (1996): 63–89, 10.1097/00042737-199601000-00012. PubMed DOI
Ginsburg P. M., Janefalkar P., Rubin D. T., and Ehrenpreis E. D., “Malabsorption Testing: A Review,” Current Gastroenterology Reports 2, no. 5 (2000): 370–377, 10.1007/s11894-000-0036-6. PubMed DOI
Sun D. F. and Fang J. Y., “Two Common Reasons of Malabsorption Syndromes: Celiac Disease and Whipple's Disease,” Digestion 74, no. 3‐4 (2006): 174–183, 10.1159/000100501. PubMed DOI
Gómez‐Escudero O. and Remes‐Troche J. M., “Approach to the Adult Patient With Chronic Diarrhea: A Literature Review,” Revista de Gastroenterología de México 86, no. 4 (2021): 387–402, 10.1016/j.rgmxen.2021.08.007. PubMed DOI
Bai J. C., “Malabsorption Syndromes,” Digestion 59, no. 5 (1998): 530–546, 10.1159/000007529. PubMed DOI
Jeppesen P. B. and Mortensen P. B., “Intestinal Failure Defined by Measurements of Intestinal Energy and Wet Weight Absorption,” Gut 46, no. 5 (2000): 701–706, 10.1136/gut.46.5.701. PubMed DOI PMC
Pironi L., Arends J., Baxter J., et al., “Home Artificial Nutrition & Chronic Intestinal Failure; Acute Intestinal Failure Special Interest Groups of ESPEN. ESPEN Endorsed Recommendations. Definition and Classification of Intestinal Failure in Adults,” Clinical Nutrition 34, no. 2 (2015): 171–180, 10.1016/j.clnu.2014.08.017. PubMed DOI
Pironi L., Cuerda C., Jeppesen P. B., et al., “ESPEN Guideline on Chronic Intestinal Failure in Adults ‐ Update 2023,” Clinical Nutrition 42, no. 10 (2023): 1940–2021, 10.1016/j.clnu.2023.07.019. PubMed DOI
Pironi L., Konrad D., Brandt C., et al., “Clinical Classification of Adult Patients With Chronic Intestinal Failure Due to Benign Disease: An International Multicenter Cross‐Sectional Survey,” Clinical Nutrition 37, no. 2 (2018): 728–738, 10.1016/j.clnu.2017.04.013. PubMed DOI
Cederholm T., Jensen G. L., Correia M. I. T. D., et al., “GLIM Criteria for the Diagnosis of Malnutrition ‐ A Consensus Report From the Global Clinical Nutrition Community,” Clinical Nutrition 38, no. 1 (2019): 1–9, 10.1016/j.clnu.2018.08.002. PubMed DOI
Cuerda C., Pironi L., Arends J., et al., “Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. ESPEN Practical Guideline: Clinical Nutrition in Chronic Intestinal Failure,” Clinical Nutrition 40, no. 9 (2021): 5196–5220, 10.1016/j.clnu.2021.07.002. PubMed DOI
Berger M. M., Shenkin A., Schweinlin A., et al., “ESPEN Micronutrient Guideline,” Clinical Nutrition 41, no. 6 (2022 Jun): 1357–1424: Epub 2022 Feb 26. Erratum in: Clin Nutr. 2024;43(4):1024. doi: 10.1016/j.clnu.2024.03.004, PubMed
10.1016/j.clnu.2022.02.015. DOI
DeLoughery T. G., Jackson C. S., Ko C. W., and Rockey D. C., “AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review,” Clinical Gastroenterology and Hepatology 22, no. 8 (2024): 1575–1583, 10.1016/j.cgh.2024.03.046. PubMed DOI
Wapnir R. A., “Copper Absorption and Bioavailability,” American Journal of Clinical Nutrition 67, no. 5 Suppl (1998): 1054S–1060S, 10.1093/ajcn/67.5.1054S. PubMed DOI
Fischer P. W., Giroux A., and L'Abbé M. R., “The Effect of Dietary Zinc on Intestinal Copper Absorption,” American Journal of Clinical Nutrition 34 (1981): 1670–1675, 10.1093/ajcn/34.9.1670. PubMed DOI
Gardner G., “Micronutrient Supplementation in Patients With Malabsorptive Conditions,” Nutrition in Clinical Practice 39, no. 5 (2024): 1102–1118, 10.1002/ncp.11190. PubMed DOI
Russell R. M., Krasinski S. D., Samloff I. M., Jacob R. A., Hartz S. C., and Brovender S. R., “Folic Acid Malabsorption in Atrophic Gastritis. Possible Compensation by Bacterial Folate Synthesis,” Gastroenterology 91, no. 6 (1986): 1476–1482, 10.1016/0016-5085(86)90204-0. PubMed DOI
Vieira de Sousa J. P., Santos‐Sousa H., Vieira S., et al., “Assessing Nutritional Deficiencies in Bariatric Surgery Patients: A Comparative Study of Roux‐En‐Y Gastric Bypass versus Sleeve Gastrectomy,” Journal of Personalized Medicine 14, no. 6 (2024): 650, 10.3390/jpm14060650. PubMed DOI PMC
Duerksen D. R., Fallows G., and Bernstein C. N., “Vitamin B12 Malabsorption in Patients With Limited Ileal Resection,” Nutrition 22, no. 11‐12 (2006): 1210–1213, 10.1016/j.nut.2006.08.017. PubMed DOI
Chen L., Chen Y., Yu X., et al., “Long‐Term Prevalence of Vitamin Deficiencies After Bariatric Surgery: A Meta‐Analysis,” Langenbeck's Archives of Surgery 409, no. 1 (2024): 226, 10.1007/s00423-024-03422-9. PubMed DOI
Stabler S. P., “Clinical Practice. Vitamin B12 Deficiency,” New England Journal of Medicine 368, no. 2 (2013): 149–160, 10.1056/NEJMcp1113996. PubMed DOI
National Research Council (US) Committee on Diet and Health , Diet and Health: Implications for Reducing Chronic Disease Risk (National Academies Press (US), 1989): 11, Fat‐Soluble Vitamins. Available from:, https://www.ncbi.nlm.nih.gov/books/NBK218749/. PubMed
Laditan A. A. and Ette S. I., “Plasma Alpha‐Tocopherol (Vitamin E) Levels and Tocopherol‐Lipid Ratio Among Children With Protein‐Energy Malnutrition (PEM),” Annals of Tropical Paediatrics 2 (1982): 85–88, 10.1080/02724936.1982.11748233. PubMed DOI
Lencovsky O., Katz‐Talmor D., and Aronoff B., “Severe Coagulopathy and Intra‐Alveolar Haemorrhage Due to Fat Malabsorption in Celiac Disease,” Eur J Case Rep Intern Med 11 (2024): 004763, 10.12890/2024_004763. PubMed DOI PMC
Narula N., Dhillon A., Zhang D., Sherlock M. E., Tondeur M., and Zachos M., “Enteral Nutritional Therapy for Induction of Remission in Crohn's Disease,” Cochrane Database of Systematic Reviews 4, no. 4 (2018): CD000542, 10.1002/14651858.CD000542.pub3. PubMed DOI PMC
Arvanitakis M., Ockenga J., Bezmarevic M., et al., “ESPEN Guideline on Clinical Nutrition in Acute and Chronic Pancreatitis,” Clinical Nutrition 39, no. 3 (2020): 612–631, 10.1016/j.clnu.2020.01.004. PubMed DOI
Bischoff S. C., Austin P., Boeykens K., et al., “ESPEN Guideline on Home Enteral Nutrition,” Clinical Nutrition 39, no. 1 (2020): 5–22, 10.1016/j.clnu.2019.04.022. PubMed DOI
Arvanitakis M., Ockenga J., Bezmarevic M., et al., “ESPEN Guideline on Clinical Nutrition in Acute and Chronic Pancreatitis,” Clinical Nutrition 39, no. 3 (2020): 612–631, 10.1016/j.clnu.2020.01.004. PubMed DOI
Pironi L., Boeykens K., Bozzetti F., et al., “ESPEN Practical Guideline: Home Parenteral Nutrition,” Clinical Nutrition 42, no. 3 (2023): 411–430, 10.1016/j.clnu.2022.12.003. PubMed DOI
Jensen G. L., Cederholm T., Correia M. I. T. D., et al., “GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community,” JPEN ‐ Journal of Parenteral and Enteral Nutrition 43, no. 1 (2019): 32–40, 10.1002/jpen.1440. PubMed DOI
Bryant R. V., Trott M. J., Bartholomeusz F. D., and Andrews J. M., “Systematic Review: Body Composition in Adults With Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics 38, no. 3 (2013): 213–225, 10.1111/apt.12372. PubMed DOI
Dhaliwal A., Quinlan J. I., Overthrow K., et al., “Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview,” Nutrients 13, no. 2 (2021): 656, 10.3390/nu13020656. PubMed DOI PMC
Barazzoni R., Jensen G. L., Correia M. I. T. D., et al., “Guidance for Assessment of the Muscle Mass Phenotypic Criterion for the Global Leadership Initiative on Malnutrition (GLIM) Diagnosis of Malnutrition,” Clinical Nutrition 41, no. 6 (2022): 1425–1433, 10.1016/j.clnu.2022.02.001. PubMed DOI
Wilcox C., Turner J., and Green J., “Systematic Review: The Management of Chronic Diarrhoea Due to Bile Acid Malabsorption,” Alimentary Pharmacology & Therapeutics 39, no. 9 (2014): 923–939, 10.1111/apt.12684. PubMed DOI
Fried M., “Octreotide in the Treatment of Refractory Diarrhea,” Digestion 60, no. Suppl 2 (1999): 42–46, 10.1159/000051479. PubMed DOI
Schultz M., Timmer A., Herfarth H. H., Sartor R. B., Vanderhoof J. A., and Rath H. C., “Lactobacillus GG in Inducing and Maintaining Remission of Crohn's Disease,” BMC Gastroenterology 4, no. 1 (2004): 5, 10.1186/1471-230X-4-5. PubMed DOI PMC
Steed H., Macfarlane G. T., Blackett K. L., et al., “Clinical Trial: The Microbiological and Immunological Effects of Synbiotic Consumption ‐ a Randomized Double‐Blind Placebo‐Controlled Study in Active Crohn's Disease,” Alimentary Pharmacology & Therapeutics 32, no. 7 (2010): 872–883, 10.1111/j.1365-2036.2010.04417.x. PubMed DOI
Limketkai B. N., Akobeng A. K., Gordon M., and Adepoju A. A., “Probiotics for Induction of Remission in Crohn's Disease,” Cochrane Database of Systematic Reviews 7, no. 7 (2020): CD006634, 10.1002/14651858.CD006634.pub3. PubMed DOI PMC
Rolfe V. E., Fortun P. J., Hawkey C. J., and Bath‐Hextall F., “Probiotics for Maintenance of Remission in Crohn's Disease,” Cochrane Database of Systematic Reviews, no. 4 (2006): CD004826, 10.1002/14651858.CD004826.pub2. PubMed DOI
Rahimi R., Nikfar S., Rahimi F., et al., “A Meta‐Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn's Disease,” Digestive Diseases and Sciences 53, no. 9 (2008): 2524–2531, 10.1007/s10620-007-0171-0. PubMed DOI
Rau S., Gregg A., Yaceczko S., and Limketkai B., “Prebiotics and Probiotics for Gastrointestinal Disorders,” Nutrients 16, no. 6 (2024): 778, 10.3390/nu16060778. PubMed DOI PMC
Joossens M., De Preter V., Ballet V., Verbeke K., Rutgeerts P., and Vermeire S., “Effect of Oligofructose‐Enriched Inulin (OF‐IN) on Bacterial Composition and Disease Activity of Patients With Crohn's Disease: Results From a Double‐Blinded Randomised Controlled Trial,” Gut 61, no. 6 (2012): 958, 10.1136/gutjnl-2011-300413. PubMed DOI
Benjamin J. L., Hedin C. R., Koutsoumpas A., et al., “Randomised, Double‐Blind, Placebo‐Controlled Trial of Fructo‐Oligosaccharides in Active Crohn's Disease,” Gut 60, no. 7 (2011): 923–929, 10.1136/gut.2010.232025. PubMed DOI
Drabińska N., Krupa‐Kozak U., and Jarocka‐Cyrta E., “Intestinal Permeability in Children With Celiac Disease After the Administration of Oligofructose‐Enriched Inulin Into a Gluten‐Free Diet‐Results of a Randomized, Placebo‐Controlled, Pilot Trial,” Nutrients 12, no. 6 (2020): 1736, 10.3390/nu12061736. PubMed DOI PMC
Di Sabatino A., Morera R., Ciccocioppo R., et al., “Oral Butyrate for Mildly to Moderately Active Crohn's Disease,” Alimentary Pharmacology & Therapeutics 22, no. 9 (2005): 789–794, 10.1111/j.1365-2036.2005.02639.x. PubMed DOI
Facchin S., Vitulo N., Calgaro M., et al., “Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease,” Neuro‐Gastroenterology and Motility 32, no. 10 (2020): e13914, 10.1111/nmo.13914. PubMed DOI PMC
Izzo K., Feczko S., and Park J. S., “Use of Oral Rehydration Solution and Intravenous Fluid in Home Settings for Adults With Short Bowel Syndrome,” Nutrition in Clinical Practice 37, no. 5 (2022): 1050–1058, 10.1002/ncp.10888. PubMed DOI
Klek S., Forbes A., Gabe S., et al., “Management of Acute Intestinal Failure: A Position Paper From the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group,” Clinical Nutrition 35, no. 6 (2016): 1209–1218, 10.1016/j.clnu.2016.04.009. PubMed DOI
Parrish C. R., Short Bowel Syndrome in Adults‐Part 3 Hydrating the Adult Patient With Short Bowel Syndrome. Series Editor PRACTICAL GASTROENTEROLOGY, (2015).
Wall E., “ORS: The Solutions to Optimize Hydration in Short Bowel Syndrome,” Nutrition Issues In Gastroenterology (2020).
Jeppesen P. B., Staun M., Tjellesen L., and Mortensen P. B., “Effect of Intravenous Ranitidine and Omeprazole on Intestinal Absorption of Water, Sodium, and Macronutrients in Patients With Intestinal Resection,” Gut 43, no. 6 (1998): 763–769, 10.1136/gut.43.6.763. PubMed DOI PMC
Aly A., Bárány F., Kollberg B., Monsén U., Wisén O., and Johansson C., “Effect of an H2‐Receptor Blocking Agent on Diarrhoeas After Extensive Small Bowel Resection in Crohn's Disease,” Acta Medica Scandinavica 207, no. 1‐2 (1980): 119–122, 10.1111/j.0954-6820.1980.tb09688.x. PubMed DOI
Pironi L., Raschi E., and Sasdelli A. S., “The Safety of Available Treatment Options for Short Bowel Syndrome and Unmet Needs,” Expert Opinion on Drug Safety 20, no. 12 (2021): 1501–1513, 10.1080/14740338.2021.1940947. PubMed DOI
Jeppesen P. B., Hartmann B., Thulesen J., et al., “Glucagon‐Like Peptide 2 Improves Nutrient Absorption and Nutritional Status in Short‐Bowel Patients With No Colon,” Gastroenterology 120, no. 4 (2001): 806–815, 10.1053/gast.2001.22555. PubMed DOI
Jeppesen P. B., Pertkiewicz M., Messing B., et al., “Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal Failure,” Gastroenterology 143, no. 6 (2012): 1473–1481.e3, 10.1053/j.gastro.2012.09.007. PubMed DOI
O'Keefe S. J., Jeppesen P. B., Gilroy R., Pertkiewicz M., Allard J. P., and Messing B., “Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure,” Clinical Gastroenterology and Hepatology 11, no. 7 (2013): 815–823.e1‐3, 10.1016/j.cgh.2012.12.029. PubMed DOI
Jeppesen P. B., Gilroy R., Pertkiewicz M., Allard J. P., Messing B., and O'Keefe S. J., “Randomised Placebo‐Controlled Trial of Teduglutide in Reducing Parenteral Nutrition And/or Intravenous Fluid Requirements in Patients With Short Bowel Syndrome,” Gut 60, no. 7 (2011): 902–914, 10.1136/gut.2010.218271. PubMed DOI PMC
Schwartz L. K., O'Keefe S. J., Fujioka K., et al., “Long‐Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome,” Clinical and Translational Gastroenterology 7, no. 2 (2016): e142, 10.1038/ctg.2015.69. PubMed DOI PMC
Solar H., Doeyo M., Ortega M., et al., “Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon‐Like Peptide‐2 Analogue (sGLP‐2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP‐2 Independency?,” JPEN ‐ Journal of Parenteral and Enteral Nutrition 45, no. 5 (2021): 1072–1082, 10.1002/jpen.1983. PubMed DOI
Pevny S., Maasberg S., Rieger A., et al., “Experience With Teduglutide Treatment for Short Bowel Syndrome in Clinical Practice,” Clinical Nutrition 38, no. 4 (2019): 1745–1755, 10.1016/j.clnu.2018.07.030. PubMed DOI
Puello F., Wall E., Herlitz J., Lozano E. S., Semrad C., and Micic D., “Long‐Term Outcomes With Teduglutide From a Single Center,” JPEN ‐ Journal of Parenteral and Enteral Nutrition 45, no. 2 (2021): 318–322, 10.1002/jpen.1838. PubMed DOI
Joly F., Seguy D., Nuzzo A., et al., “Six‐Month Outcomes of Teduglutide Treatment in Adult Patients With Short Bowel Syndrome With Chronic Intestinal Failure: A Real‐World French Observational Cohort Study,” Clinical Nutrition 39, no. 9 (2020): 2856–2862, 10.1016/j.clnu.2019.12.019. PubMed DOI
Gigola F., Cianci M. C., Cirocchi R., et al., “Use of Teduglutide in Children With Intestinal Failure: A Systematic Review,” Frontiers in Nutrition 9 (2022): 866518, 10.3389/fnut.2022.866518. PubMed DOI PMC
Armstrong D., Forbes A., Jeppesen P. B., Lee H. M., Nagy P., and Seidner D. L., “Colon Polyps in Patients With Short Bowel Syndrome Before and After Teduglutide: Post Hoc Analysis of the STEPS Study Series,” Clinical Nutrition 39, no. 6 (2020): 1774–1777, 10.1016/j.clnu.2019.08.020. PubMed DOI
Abu‐Elmagd K. M., Armanyous S. R., Fujiki M., et al., “Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation versus Transplantation With a Novel Predictive Model,” Annals of Surgery 270, no. 4 (2019): 656–674, 10.1097/SLA.0000000000003523. PubMed DOI
van Praagh J. B., Hofker H. S., and Haveman J. W., “Comparing Bowel Lengthening Procedures: Which, When, and Why?,” Current Opinion in Organ Transplantation 27, no. 2 (2022): 112–118, 10.1097/MOT.0000000000000957. PubMed DOI PMC
Sudan D., Thompson J., Botha J., et al., “Comparison of Intestinal Lengthening Procedures for Patients With Short Bowel Syndrome,” Annals of Surgery 246, no. 4 (2007): 593–601: discussion 601‐4, 10.1097/SLA.0b013e318155aa0c. PubMed DOI
Jones B. A., Hull M. A., Potanos K. M., et al., “Report of 111 Consecutive Patients Enrolled in the International Serial Transverse Enteroplasty (STEP) Data Registry: A Retrospective Observational Study,” Journal of the American College of Surgeons 216, no. 3 (2013): 438–446, 10.1016/j.jamcollsurg.2012.12.018. PubMed DOI PMC
Butt W. T., Ryan ÉJ., Boland M. R., et al., “Strictureplasty Versus Bowel Resection for the Surgical Management of Fibrostenotic Crohn's Disease: A Systematic Review and Meta‐Analysis,” International Journal of Colorectal Disease 35, no. 4 (2020): 705–717, 10.1007/s00384-020-03507-z. PubMed DOI
Kaufman S. S., Avitzur Y., Beath S. V., et al., “New Insights Into the Indications for Intestinal Transplantation: Consensus in the Year 2019,” Transplantation 104, no. 5 (2020): 937–946, 10.1097/TP.0000000000003065. PubMed DOI PMC
Hogue G. and Adams R., “Lower Gastrointestinal Conditions: Malabsorption Syndromes,” FP Essent. 483 (2019): 20–24. PubMed
Alkalay M. J., “Nutrition in Patients With Lactose Malabsorption, Celiac Disease, and Related Disorders,” Nutrients 14, no. 1 (2021): 2, 10.3390/nu14010002. PubMed DOI PMC
Therrien A., Kelly C. P., and Silvester J. A., “Celiac Disease: Extraintestinal Manifestations and Associated Conditions,” Journal of Clinical Gastroenterology 54, no. 1 (2020): 8–21, 10.1097/MCG.0000000000001267. PubMed DOI PMC
Leffler D. A., Green P. H., and Fasano A., “Extraintestinal Manifestations of Coeliac Disease,” Nature Reviews Gastroenterology & Hepatology 12, no. 10 (2015): 561–571, 10.1038/nrgastro.2015.131. PubMed DOI
Di Rienzo T., D'Angelo G., D'Aversa F., et al., “Lactose Intolerance: From Diagnosis to Correct Management,” European Review for Medical and Pharmacological Sciences 17, no. Suppl 2 (2013): 18–25. PubMed
Caio G., Volta U., Sapone A., et al., “Celiac Disease: A Comprehensive Current Review,” BMC Medicine 17, no. 1 (2019): 142, 10.1186/s12916-019-1380-z. PubMed DOI PMC
Gujral N., Freeman H. J., and Thomson A. B., “Celiac Disease: Prevalence, Diagnosis, Pathogenesis and Treatment,” World Journal of Gastroenterology 18, no. 42 (2012): 6036–6059, 10.3748/wjg.v18.i42.6036. PubMed DOI PMC
Pascual V., Dieli‐Crimi R., López‐Palacios N., Bodas A., Medrano L. M., and Núñez C., “Inflammatory Bowel Disease and Celiac Disease: Overlaps and Differences,” World Journal of Gastroenterology 20, no. 17 (2014): 4846–4856, 10.3748/wjg.v20.i17.4846. PubMed DOI PMC
Kelly C. P., Bai J. C., Liu E., and Leffler D. A., “Advances in Diagnosis and Management of Celiac Disease,” Gastroenterology 148, no. 6 (2015): 1175–1186, 10.1053/j.gastro.2015.01.044. PubMed DOI PMC
Harper A. M., Banks J., Elwenspoek M., et al., “Navigating Coeliac Disease Diagnosis in Primary Care,” British Journal of General Practice 74, no. 739 (2024): 52–53, 10.3399/bjgp24X736137. PubMed DOI PMC
Guigoz Y., Lauque S., and Vellas B. J., “Identifying the Elderly at Risk for Malnutrition. The Mini Nutritional Assessment,” Clinics in Geriatric Medicine 18, no. 4 (2002): 737–757, 10.1016/s0749-0690(02)00059-9. PubMed DOI
Lindner‐Rabl S., Wagner V., Matijevic A., et al., “Clinical Interventions to Improve Nutritional Care in Older Adults and Patients in Primary Healthcare ‐ A Scoping Review of Current Practices of Health Care Practitioners,” Clinical Interventions in Aging 17 (2022): 1–13, 10.2147/CIA.S343307. PubMed DOI PMC
Lee L. C., Tsai A. C., and Wang J. Y., “Need‐Based Nutritional Intervention Is Effective in Improving Handgrip Strength and Barthel Index Scores of Older People Living in a Nursing Home: A Randomized Controlled Trial,” International Journal of Nursing Studies 52, no. 5 (2015): 904–912, 10.1016/j.ijnurstu.2015.01.008. PubMed DOI
Lu Y., Niti M., Yap K. B., et al., “Effects of Multi‐Domain Lifestyle Interventions on Sarcopenia Measures and Blood Biomarkers: Secondary Analysis of a Randomized Controlled Trial of Community‐Dwelling Pre‐Frail and Frail Older Adults,” Aging (Albany NY) 13, no. 7 (2021): 9330–9347, 10.18632/aging.202705. PubMed DOI PMC
Lupton J. R., Blumberg J. B., L'Abbe M., et al., “Nutrient Reference Value: Non‐Communicable Disease Endpoints‐‐a Conference Report,” European Journal of Nutrition 55, no. Suppl 1 (2016): S1–S10, 10.1007/s00394-016-1195-z. PubMed DOI PMC
Lingervelder D., Koffijberg H., Kusters R., and Ijzerman M. J., “Point‐Of‐Care Testing in Primary Care: A Systematic Review on Implementation Aspects Addressed in Test Evaluations,” International Journal of Clinical Practice 73, no. 10 (2019): e13392, 10.1111/ijcp.13392. PubMed DOI PMC
Barcellona D., Fenu L., Cornacchini S., and Marongiu F., “Point‐Of‐Care (POCT) Prothrombin Time Monitors: Is a Periodical Control of Their Performance Useful?,” Thrombosis Research 123, no. 5 (2009): 775–779, 10.1016/j.thromres.2008.08.006. PubMed DOI
Elia M. and Stratton R. J., “An Analytic Appraisal of Nutrition Screening Tools Supported by Original Data With Particular Reference to Age,” Nutrition 28, no. 5 (2012): 477–494, 10.1016/j.nut.2011.11.009. PubMed DOI
Ong S., Woo J., Parikh P., et al., “Addressing Nutritional Requirements of Ageing Consumers in Asia‐Recommendations From an Expert Workshop,” Asia Pacific Journal of Clinical Nutrition 28, no. 2 (2019): 204–213, 10.6133/apjcn.201906_28(2).0001. PubMed DOI
Poulia K. A., Klek S., Doundoulakis I., et al., “The Two Most Popular Malnutrition Screening Tools in the Light of the New ESPEN Consensus Definition of the Diagnostic Criteria for Malnutrition,” Clinical Nutrition 36, no. 4 (2017): 1130–1135, 10.1016/j.clnu.2016.07.014. PubMed DOI
Misselwitz B., Butter M., Verbeke K., and Fox M. R., “Update on Lactose Malabsorption and Intolerance: Pathogenesis, Diagnosis and Clinical Management,” Gut 68, no. 11 (2019): 2080–2091, 10.1136/gutjnl-2019-318404. PubMed DOI PMC
Clark A. B., Reijnierse E. M., Lim W. K., and Maier A. B., “Prevalence of Malnutrition Comparing the GLIM Criteria, ESPEN Definition and MST Malnutrition Risk in Geriatric Rehabilitation Patients: RESORT,” Clinical Nutrition 39, no. 11 (2020 Nov): 3504–3511, 10.1016/j.clnu.2020.03.015. PubMed DOI